Tara Bouton, MD, MPH

Assistant Professor, Medicine

Tara Bouton
617.414.5213

Biography

Dr. Tara C. Bouton is an Assistant Professor of Medicine at Boston University School of Medicine and an attending physician in the Section of Infectious Diseases at Boston Medical Center. Dr. Bouton’s research focuses on the impact of HIV infection on evolution and transmission of drug resistant tuberculosis and improving outcomes in both diseases. She is also working to better understand transmission and viral dynamics of SARS-CoV-2 variants. She has lived and worked in Brazil, Ghana, Botswana, and South Africa.

Education

  • Tulane University School of Medicine, MD
  • Tulane University School of Public Health and Tropical Medicine, MPH
  • Colby College, BA

Publications

  • Published on 6/23/2022

    Bouton TC, Atarere J, Turcinovic J, Seitz S, Sher-Jan C, Gilbert M, White L, Zhou Z, Hossain MM, Overbeck V, Doucette-Stamm L, Platt J, Landsberg HE, Hamer DH, Klapperich C, Jacobson KR, Connor JH. Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study. Clin Infect Dis. 2022 Jun 23. PMID: 35737948.

    Read at: PubMed
  • Published on 5/25/2022

    Petros BA, Turcinovic J, Welch NL, White LF, Kolaczyk ED, Bauer MR, Cleary M, Dobbins ST, Doucette-Stamm L, Gore M, Nair P, Nguyen TG, Rose S, Taylor BP, Tsang D, Wendlandt E, Hope M, Platt JT, Jacobson KR, Bouton T, Yune S, Auclair JR, Landaverde L, Klapperich CM, Hamer DH, Hanage WP, MacInnis BL, Sabeti PC, Connor JH, Springer M. Early introduction and rise of the Omicron SARS-CoV-2 variant in highly vaccinated university populations. Clin Infect Dis. 2022 May 25. PMID: 35616119.

    Read at: PubMed
  • Published on 4/5/2022

    Bouton TC, Atarere J, Turcinovic J, Seitz S, Sher-Jan C, Gilbert M, White L, Zhou Z, Hossain MM, Overbeck V, Doucette-Stamm L, Platt J, Landsberg HE, Hamer DH, Klapperich C, Jacobson KR, Connor JH. Viral dynamics of Omicron and Delta SARS-CoV-2 variants with implications for timing of release from isolation: a longitudinal cohort study. medRxiv. 2022 Apr 05. PMID: 35411341.

    Read at: PubMed
  • Published on 3/31/2022

    Wigger GW, Bouton TC, Jacobson KR, Auld SC, Yeligar SM, Staitieh BS. The Impact of Alcohol Use Disorder on Tuberculosis: A Review of the Epidemiology and Potential Immunologic Mechanisms. Front Immunol. 2022; 13:864817. PMID: 35432348.

    Read at: PubMed
  • Published on 9/17/2021

    Bouton TC, Lodi S, Turcinovic J, Schaeffer B, Weber SE, Quinn E, Korn C, Steiner J, Schechter-Perkins EM, Duffy E, Ragan EJ, Taylor BP, Miller N, Davidoff R, Hanage WP, Connor J, Pierre C, Jacobson KR. Coronavirus Disease 2019 Vaccine Impact on Rates of Severe Acute Respiratory Syndrome Coronavirus 2 Cases and Postvaccination Strain Sequences Among Health Care Workers at an Urban Academic Medical Center: A Prospective Cohort Study. Open Forum Infect Dis. 2021 Oct; 8(10):ofab465. PMID: 34646910.

    Read at: PubMed
  • Published on 9/9/2021

    Barocas JA, Savinkina A, Lodi S, Epstein RL, Bouton TC, Sperring H, Hsu HE, Jacobson KR, Schechter-Perkins EM, Linas BP, White LF. Projected long-term impact of the COVID-19 pandemic on hepatitis C outcomes in the United States: a modelling study. Clin Infect Dis. 2021 Sep 09. PMID: 34499124.

    Read at: PubMed
  • Published on 7/1/2021

    Bouton TC, Jacobson KR. Symptom Screens Are Not Sufficient: The Fight Against Tuberculosis Needs Better Weapons. Clin Infect Dis. 2021 07 01; 73(1):121-123. PMID: 32296819.

    Read at: PubMed
  • Published on 6/16/2021

    Ragan EJ, Gill CJ, Banos M, Bouton TC, Rooney J, Horsburgh CR, Warren RM, Myers B, Jacobson KR. Directly Observed Therapy to Measure Adherence to Tuberculosis Medication in Observational Research: Protocol for a Prospective Cohort Study. JMIR Res Protoc. 2021 Jun 16; 10(6):e24510. PMID: 34132642.

    Read at: PubMed
  • Published on 5/20/2021

    Epstein RL, Sperring H, Hofman M, Lodi S, White LF, Barocas JA, Bouton TC, Xiao Y, Hsu HE, Miller NS, Linas BP, Marathe JG. Time to SARS-CoV-2 PCR Clearance in Immunocompromising Conditions: Is Test-Based Removal From Isolation Necessary in Severely Immunocompromised Individuals? Open Forum Infect Dis. 2021 Jun; 8(6):ofab164. PMID: 34189164.

    Read at: PubMed
  • Published on 5/19/2021

    Myers B, Carney T, Rooney J, Malatesta S, White LF, Parry CDH, Bouton TC, Ragan EJ, Horsburgh CR, Warren RM, Jacobson KR. Alcohol and Tobacco Use in a Tuberculosis Treatment Cohort during South Africa's COVID-19 Sales Bans: A Case Series. Int J Environ Res Public Health. 2021 05 19; 18(10). PMID: 34069737.

    Read at: PubMed

View 11 more publications: View full profile at BUMC

View all profiles